Epitalon For Anti-Aging Agents CAS:307297-39-8

    What is Epitalon? From Pineal Mystery to Synthetic Molecule

    Epitalon's origin story begins with Epithalamin, a complex polypeptide fraction isolated from the pineal gland of calves by Russian scientist Professor Vladimir Dilman and later extensively studied by Professor Vladimir Khavinson. Early research suggested Epithalamin possessed remarkable geroprotective (aging-protective) properties, including normalizing melatonin synthesis, improving immune function, and extending lifespan in animal models.

    Recognizing the challenges of standardizing and producing a natural glandular extract, Khavinson's team embarked on a quest to identify its most biologically active component. Through meticulous analysis, they pinpointed a specific amino acid sequence: Alanine-Glutamic Acid-Aspartic Acid-Glycine (Ala-Glu-Asp-Gly). Synthesizing this sequence resulted in Epitalon (Epithalon), a pure, standardized peptide replicating the core activity observed in the natural extract.

    Thus, Epitalon is not a naturally occurring hormone itself, but a scientifically designed, synthetic peptide mimicking the key bioactive message believed to be conveyed by the pineal gland's Epithalamin concerning longevity regulation. Its creation represents a triumph of peptide chemistry applied to gerontology.

 

    Epitalon's proposed anti-aging effects stem from influencing several fundamental biological processes:

    ●Telomerase Activation & Telomere Stabilization: This is arguably Epitalon's most researched and compelling feature. Telomeres, the protective caps on chromosome ends, shorten with each cell division (the Hayflick limit), acting as a molecular clock for cellular aging. Epitalon appears to upregulate the expression and activity of telomerase, the enzyme responsible for adding DNA repeats to telomeres. Studies (primarily in vitro and animal models) demonstrate Epitalon's ability to slow telomere attrition, maintain telomere length, and even modestly elongate telomeres in certain cell types. This directly challenges a primary mechanism of replicative senescence.

    ●Epigenetic Modulation & Gene Expression Normalization: Aging is accompanied by dysregulation of gene expression, often linked to epigenetic changes (chemical modifications to DNA/histones altering gene activity without changing the DNA sequence). Epitalon has been shown to modulate the expression of genes involved in cell cycle regulation, DNA repair, stress response, and apoptosis (programmed cell death). Notably, it appears to normalize the expression of aging-associated genes, potentially shifting cells towards a more youthful transcriptional profile. Research suggests it influences chromatin structure and may impact key epigenetic regulators.

    ●Enhanced DNA Repair: Genomic instability is a hallmark of aging. Epitalon demonstrates the ability to stimulate intrinsic DNA repair mechanisms. Studies indicate it can increase the activity of enzymes involved in repairing DNA damage caused by oxidative stress and other insults, thereby promoting genomic integrity and reducing mutation accumulation.

    ●Antioxidant System Stimulation: While not a direct antioxidant itself, Epitalon appears to upregulate the body's endogenous antioxidant defense systems, including enzymes like superoxide dismutase (SOD) and catalase. This boosts cellular resilience against oxidative stress, a major contributor to aging and age-related pathologies.

    ●Pineal Regulation & Melatonin Synthesis: Reflecting its origin, Epitalon can stimulate the secretion of melatonin from the pineal gland, particularly in aged organisms where pineal function declines. Melatonin itself is a potent antioxidant and regulator of circadian rhythms, both crucial for healthy aging. Epitalon helps restore this rhythmicity.

    ●Senescence Modulation: Cellular senescence (the irreversible arrest of cell division) contributes to aging and inflammation via the senescence-associated secretory phenotype (SASP). Evidence suggests Epitalon may reduce the burden of senescent cells and potentially dampen the harmful SASP, promoting a healthier tissue microenvironment.

    Based on its mechanisms, Epitalon's potential applications extend beyond a vague "anti-aging" goal to specific physiological systems and conditions:

    ●Mitigating Cellular Aging: Directly targeting telomere maintenance and senescence to prolong the replicative lifespan and functional capacity of cells (fibroblasts, immune cells, stem cells).

    ●Neuroprotection & Cognitive Health: Supporting neuronal DNA repair, reducing oxidative stress in the brain, potentially slowing neurodegeneration, and improving cognitive function in aging models. Its influence on melatonin also supports circadian health, vital for cognition.

    ●Cardiovascular Protection: Enhancing endothelial function (blood vessel lining), reducing oxidative stress in cardiovascular tissues, and potentially improving resilience against age-related cardiovascular diseases.

    ●Ocular Health: Research shows promise in preventing age-related retinal degeneration (e.g., retinitis pigmentosa models) by protecting retinal cells and supporting function.

    ●Immune System Rejuvenation: Counteracting age-related immune decline (immunosenescence) by normalizing immune cell function, potentially improving response to pathogens and vaccines in the elderly.

    ●Metabolic Health: Modulating gene expression related to metabolism and insulin sensitivity, potentially offering benefits against age-related metabolic dysfunction.

    ●Cancer Prevention (Theoretical/Preclinical): By promoting genomic stability (enhanced DNA repair, telomere maintenance) and reducing inflammation, Epitalon may theoretically lower cancer risk associated with aging, though this requires immense caution and research. It is NOT a cancer treatment.

    The culmination of its features and applications points towards significant potential benefits:

    ●Increased Healthspan: The primary goal – extending the period of life spent in good health, free from major age-related diseases and disability.

    ●Slowed Biological Aging: As measured by biomarkers like telomere length, epigenetic clocks (e.g., DNA methylation patterns), and physiological function.

    ●Enhanced Cellular Resilience: Improved ability of cells to withstand stress (oxidative, genotoxic) and maintain function.

    ●Improved Tissue Regeneration: Potentially supporting stem cell function and tissue repair capacity.

    ●Restored Circadian Rhythms: Leading to better sleep quality and overall metabolic/neurological health.

    ●Reduced Systemic Inflammation: By modulating senescence and immune function, potentially lowering chronic low-grade inflammation (inflammaging).

    ●Preserved Cognitive Function: Supporting brain health and potentially delaying cognitive decline.

    Crucial Disclaimer: Epitalon is not approved by the FDA, EMA, or any major regulatory body for human use as an anti-aging drug. Human data is extremely limited, primarily derived from small observational studies or anecdotal reports within the biohacking community. The following information is based on preclinical research and common practices in experimental use; it is NOT medical advice.

    ●Dosage: Human protocols often extrapolate from animal studies. Common experimental dosages range from 1mg to 10mg per day, with 5mg daily being a frequently cited point. Higher doses (e.g., 10mg) are sometimes used but lack robust evidence for increased efficacy or safety.

    ●Administration: Epitalon is typically administered via subcutaneous (SubQ) injection due to poor oral bioavailability. It is reconstituted with bacteriostatic water before injection. Intranasal administration is sometimes explored but has less established efficacy.

    ●Cycle: Based on the pioneering work of Khavinson and anecdotal reports, a common protocol involves a relatively short, intensive cycle:

    ○Duration: 10 to 20 consecutive days.

    ○Frequency: Once daily injection (usually in the evening, potentially aligning with natural pineal activation).

    ○Frequency per Year: Often repeated 1-2 times per year (e.g., every 6 months). The rationale stems from the hypothesis that a short burst of therapy provides a sustained epigenetic/telomeric reset, with effects potentially lasting months. Long-term, continuous daily use is less common and not well-supported by current understanding.

    ●Rationale for Short Cycles: The focus is on triggering a cellular reprogramming response (telomerase activation, epigenetic shifts) rather than providing continuous hormonal replacement. The sustained effects observed in animal models after cessation of treatment support this intermittent approach.

    Epitalon has a very short plasma half-life, estimated to be in the range of 20 to 30 minutes in preclinical models. This rapid clearance is typical for small, unprotected peptides due to enzymatic degradation (peptidases) and renal filtration.

    ●Implications:

    ○Transient Exposure: Its biological effects are not due to sustained high blood levels but rather to the triggering of downstream signaling cascades and gene expression changes initiated during its brief presence.

    ○Dosing Frequency: While the half-life is short, the once-daily dosing protocol used in cycles is based on the observation that this pulse is sufficient to elicit the desired epigenetic and enzymatic responses that persist long after the peptide is cleared. More frequent dosing (e.g., multiple times per day) is not typically employed or shown to be necessary.

    ○Route Matters: The short half-life reinforces why injection (SubQ or potentially IM) is the primary route, bypassing the digestive system where oral bioavailability would be negligible.

Trade Name	Epithalon, Epithalone, Ala-Glu-Asp-Gly
CAS	307297-39-8
Molar mass	390.349
Formula	C14H22N4O9
Purity	Above 98%
Apprarance	10mg/vial,Lyophilized powder

 

 

Any needs, please contact us

Email: Jasonraws106@gmail.com

WhatsApp: +86-15572565525
Telegram: +86-15871669785

   

                                   

 

    Epitalon represents a fascinating and scientifically grounded approach to anti-aging, distinct from hormone replacement or simple antioxidant strategies. Its core proposition – synthetically replicating a pineal-derived signal to modulate telomerase, epigenetics, DNA repair, and antioxidant defenses – targets fundamental pillars of the aging process. The preclinical data, particularly from Professor Khavinson's decades-long research program, is compelling, showing lifespan extension and healthspan improvement in various animal models.

    However, significant gaps remain. Robust, large-scale, long-term human clinical trials are lacking. The existing human data is preliminary and observational. While its safety profile in limited use appears favorable, comprehensive human toxicology data is absent. The precise mechanisms, especially the receptor(s) it engages (if any) to initiate its wide-ranging effects, are still being elucidated. Its very short half-life underscores that its power lies in signaling, not persistence.

    Therefore, Epitalon should be viewed as a highly promising, yet still experimental, geroprotective peptide. It embodies the potential of targeting aging at its roots but resides firmly within the realm of research and cautious biohacking exploration, not established medical practice. Its true potential for safely and effectively extending human healthspan awaits validation through rigorous clinical science. For now, it remains a powerful symbol of the quest to understand and influence the deep biological clocks governing our lifespan.

Hot Tags: epitalon for anti-aging agents cas:307297-39-8, China epitalon for anti-aging agents cas:307297-39-8 manufacturers, suppliers, factory